Key Record Dates
ClinicalTrials.gov Identifier: | NCT03016091 |
---|---|
Brief Title: | A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma |
First Submitted : | December 22, 2016 |
First Submitted that Met QC Criteria : | January 9, 2017 |
First Posted : | January 10, 2017 (Estimate) |
Last Update Submitted that Met QC Criteria : | April 16, 2019 |
Last Update Posted : | April 18, 2019 |